Arcturus Therapeutics Holdings Inc.
Status: Publicly traded
Direct answer
Arcturus Therapeutics Holdings Inc. is publicly traded on NASDAQ under the ticker ARCT.
Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) deficiency, and LUNAR-CF, targeting cystic fibrosis lung disease caused by...
Can you invest in Arcturus Therapeutics Holdings Inc.?
Yes. Arcturus Therapeutics Holdings Inc. trades publicly on NASDAQ as ARCT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Arcturus Therapeutics Holdings Inc.
Detailed equity research is provided by MarketSnap.